Top Markets
Coin of the day
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
株式のランク #40868
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
株価
$0.02765
最終同期: 2024-12-23
時価総額
$69.04K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Histogen Inc. (HSTO)

カテゴリー

Histogen Inc.(HSTO)の株式分割履歴
Histogen Inc.株(シンボル:HSTO)は合計で2回の株式分割を実施しました。
最新の株式分割はJun 03, 2022に行われました。
May 27, 2020より前に購入されたHSTO株は、現在0.005HSTO株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
2022-06-03 1:20 x0.05 x0.005
2020-05-27 1:10 x0.1 x0.1
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE